Johnson & Johnson (JNJ): Rep. Ritchie Torres (NY15) disclosed a purchase $1K–$15K
Rep. Ritchie Torres (NY15) disclosed a purchase of Johnson & Johnson in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 328 days
- Disclosure lag
- Traded
- Sep 26, 2024
- Disclosed
- Aug 20, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jul 14, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Nov 10, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Jul 1, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Jul 2, 2024Congress · 1 personMembers of Congress: 2 purchases
- Jul 3, 2024Congress · 1 personMembers of Congress: 2 sales
- Jul 16, 2024CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
- Aug 2, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Aug 7, 2024CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
- Sep 4, 2024CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
- Sep 10, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
What came next
- Oct 29, 2024CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
- Nov 8, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Nov 22, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Nov 25, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Nov 26, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Dec 6, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Dec 10, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Dec 12, 2024InsiderDirector purchased ~$147K of JNJ shares in the open market
- Dec 12, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Dec 18, 2024FDAFDA drug approval: Invokamet XR
- Dec 18, 2024FDAFDA drug approval: Invokamet
- Dec 20, 2024FDARecall: PROLENE Polypropylene Suture, REF: EH7585H, 8706H, 8833H, 8963H, 8935H PROLENE Suture is indicated for use in general soft tissue approximation and/or ligation…
- Dec 20, 2024FDARecall: ETHIBOND EXCEL Polyester Suture, REF: 6664H, X425H, X872H, EH7491H. Not sold in US
- Dec 20, 2024FDARecall: PERMA-HAND Silk Suture, REF: K872H, W723H, 623H, K833H; Perma-hand Silk Suture is indicated for use in general soft tissue approximation and/or ligation, inclu…
- Dec 23, 2024FDAFDA device clearance: INHANCE INTACT
- Dec 24, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Dec 31, 2024CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
- Jan 5, 2025FDARecall: VARIPULSE Bi-Directional Ablation Catheter REF D141201. The Field Catheter is indicated for use in catheter based cardiac electrophysiological mapping (stimula…
- Jan 12, 2025FDAFDA device clearance: Mentor CPX 4 PLUS Enhance Breast Tissue Expander
- Jan 13, 2025FDAFDA device clearance: MENTOR MemoryShape Resterilizable Gel Breast Implant Sizer; MENTOR MemoryGel Resterilizable Gel Breast Implant Sizer; MENTOR MemoryGel Enhance Single Use…
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Johnson & Johnson
For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.
Other recent filings by Rep. Ritchie Torres (NY15)
- House Clerk periodic transaction report at McKesson Corporation (MCK)Jul 8, 2026
- House Clerk periodic transaction report at PepsiCo (PEP)Aug 20, 2025
- House Clerk periodic transaction report at Marvell Technology (MRVL)Aug 20, 2025
- House Clerk periodic transaction report at AbbVie (ABBV)Aug 20, 2025
- House Clerk periodic transaction report at AbbVie (ABBV)Aug 20, 2025
The full history of Rep. Ritchie Torres (NY15) is on the profile page.
How this filing works
Explore the data
Other disclosures at Johnson & Johnson
- House Clerk periodic transaction reportOct 5, 2026
- USAspending.gov award recordOct 5, 2026
- USAspending.gov award recordSep 24, 2026
- USAspending.gov award recordSep 22, 2026
- USAspending.gov award recordSep 21, 2026
- House Clerk periodic transaction reportSep 12, 2026
Everything OQRO holds on this company is on its JNJ page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
